Pardes Biosciences PRDS Stock
2.16 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
133.95M USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Pardes Biosciences Price Chart
Pardes Biosciences PRDS Financial and Trading Overview
| Pardes Biosciences stock price | 2.16 USD |
| Previous Close | 1.84 USD |
| Open | 1.84 USD |
| Bid | 0 USD x 2200 |
| Ask | 0 USD x 1000 |
| Day's Range | 1.83 - 1.9 USD |
| 52 Week Range | 0.75 - 5.07 USD |
| Volume | 78.95K USD |
| Avg. Volume | 287.12K USD |
| Market Cap | 117.26M USD |
| Beta (5Y Monthly) | 0.416541 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.75 USD |
PRDS Valuation Measures
| Enterprise Value | -61884952 USD |
| Trailing P/E | N/A |
| Forward P/E | -38 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6916636 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Pardes Biosciences Stock Price History
| Beta (5Y Monthly) | 0.416541 |
| 52-Week Change | -61.065% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.07 USD |
| 52 Week Low | 0.75 USD |
| 50-Day Moving Average | 1.84 USD |
| 200-Day Moving Average | 1.69 USD |
PRDS Share Statistics
| Avg. Volume (3 month) | 287.12K USD |
| Avg. Daily Volume (10-Days) | 107.62K USD |
| Shares Outstanding | 61.72M |
| Float | 18.55M |
| Short Ratio | 18.59 |
| % Held by Insiders | 13.50% |
| % Held by Institutions | 72.84% |
| Shares Short | 1.95M |
| Short % of Float | 9.10% |
| Short % of Shares Outstanding | 3.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.46% |
| Return on Equity (ttm) | -45.24% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -92999000 USD |
| Diluted EPS (ttm) | -1.55 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 172.23M USD |
| Total Cash Per Share (mrq) | 2.87 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 15.431 |
| Book Value Per Share (mrq) | 2.747 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -78147000 USD |
| Levered Free Cash Flow (ttm) | -44041624 USD |
Profile of Pardes Biosciences
| Country | United States |
| State | CA |
| City | Carlsbad |
| Address | 2173 Salk Avenue |
| ZIP | 92008 |
| Phone | 415 649 8758 |
| Website | https://www.pardesbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 57 |
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.
Q&A For Pardes Biosciences Stock
What is a current PRDS stock price?
Pardes Biosciences PRDS stock price today per share is 2.16 USD.
How to purchase Pardes Biosciences stock?
You can buy PRDS shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pardes Biosciences?
The stock symbol or ticker of Pardes Biosciences is PRDS.
Which industry does the Pardes Biosciences company belong to?
The Pardes Biosciences industry is Biotechnology.
How many shares does Pardes Biosciences have in circulation?
The max supply of Pardes Biosciences shares is 62.01M.
What is Pardes Biosciences Price to Earnings Ratio (PE Ratio)?
Pardes Biosciences PE Ratio is 0.00000000 now.
What was Pardes Biosciences earnings per share over the trailing 12 months (TTM)?
Pardes Biosciences EPS is 0 USD over the trailing 12 months.
Which sector does the Pardes Biosciences company belong to?
The Pardes Biosciences sector is Healthcare.
Pardes Biosciences PRDS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}